Ex-Exec Admits Faking Cancer To Duck SEC
The former head of regulatory affairs at Biopure Corp. has pled guilty to faking terminal colon cancer to thwart U.S. Securities and Exchange Commission litigation alleging the company and its employees...To view the full article, register now.
Already a subscriber? Click here to view full article